Liver injury in cystic fibrosis: How to distinguish drug-induced liver injury from cystic fibrosis liver disease?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 10

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Mar 14, 2026; 32(10): 114946
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.114946

Full Size Figure Download Figure

Figure 1 PRISMA flow diagram on selection of studies.

Citation: Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P. Liver injury in cystic fibrosis: How to distinguish drug-induced liver injury from cystic fibrosis liver disease? World J Gastroenterol 2026; 32(10): 114946
URL: https://www.wjgnet.com/1007-9327/full/v32/i10/114946.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i10.114946

Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P. Liver injury in cystic fibrosis: How to distinguish drug-induced liver injury from cystic fibrosis liver disease? World J Gastroenterol 2026; 32(10): 114946 [PMID: 41809454 DOI: 10.3748/wjg.v32.i10.114946]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.